{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:42:23Z","timestamp":1790754143282,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neubiorev.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:56:50Z","timestamp":1536713810000},"page":"133-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["New synthetic opioids: Part of a new addiction landscape"],"prefix":"10.1016","volume":"106","author":[{"given":"Laurent","family":"Karila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-8062","authenticated-orcid":false,"given":"Maude","family":"Marillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-2788","authenticated-orcid":false,"given":"Boris","family":"Chaumette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Billieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Franchitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2018.06.010_bib0005","series-title":"Agence Nationale de S\u00e9curit\u00e9 des M\u00e9dicaments et des Produits de Sant\u00e9 (ANSM). Commission des stup\u00e9fiants et psychotropes: Compte rendu de la s\u00e9ance du 12 janvier 2017","author":"ANSM","year":"2017"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.06.010_bib0010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0015","series-title":"Agence R\u00e9gionale de Sant\u00e9 Ile de France. Note d\u2019information: Circulation sur le Deep Web d\u2019h\u00e9ro\u00efne coup\u00e9e \u00e0 l\u2019ocfentanil","author":"ARS","year":"2015"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.06.010_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0025","series-title":"Canadian Community Epidemiology Network on Drug Use. CCENDU Bulletin: Deaths Involving Fentanyl in Canada (2009\u20132014)","author":"CCENDU","year":"2015"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2878","article-title":"Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage","volume":"135","author":"Cole","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.forsciint.2016.07.005","article-title":"Ocfentenil overdose fatality in the recreational drug scene","volume":"266","author":"Coopman","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.06.010_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/dar.12216","article-title":"AH-7921: a new synthetic opioid of abuse","volume":"34","author":"Coppola","year":"2015","journal-title":"Drug. Alcohol. Rev."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0045","series-title":"U.S. Department of Justice Drug Enforcement Administration. DEA Issues Nationwide Alert on Fentanyl as Threat to Health and Public Safety","author":"DEA","year":"2015"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0050","series-title":"U.S. Department of Justice Drug Enforcement Administration. Counterfeit Prescription Pills Containing Fentanyls: A Global Threat","author":"DEA","year":"2016"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0055","series-title":"Fentanyl in Europe, EMCDDA Trendspotter Study Report","author":"EMCDDA","year":"2012"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0060","series-title":"European Monitoring Centre for Drugs and Drug Addiction. High-Risk Drug Use and New Psychoactive Substances, EMCDDA Rapid Communication","author":"EMCDDA","year":"2017"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0065","series-title":"European Drug Report 2017: Trends and Developments","author":"EMCDDA","year":"2017"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.06.010_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01225419","article-title":"Fatality due to fentanyl-cocaine intoxication resulting in a fall","volume":"106","author":"Ferrara","year":"1994","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2016.12.021","article-title":"Desomorphine (Krokodil): an overview of its chemistry, pharmacology, metabolism, toxicology and analysis","volume":"173","author":"Florez","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0080","first-page":"219","article-title":"The pharmacological basis of opioids","volume":"12","author":"Ghelardini","year":"2015","journal-title":"Clin. Cases Min. Bone Metab."},{"issue":"10","key":"10.1016\/j.neubiorev.2018.06.010_bib0085","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.06.010_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugpo.2013.04.007","article-title":"Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia","volume":"24","author":"Grund","year":"2013","journal-title":"Int. J. Drug. Policy"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0095","first-page":"242","article-title":"Postmortem and toxicological findings in a series of furanylfentanyl-related deaths","volume":"41","author":"Guerrieri","year":"2017","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.06.010_bib0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","article-title":"Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project","volume":"54","author":"Helander","year":"2016","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.06.010_bib0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","article-title":"Intoxications involving acrylfentanyl and other novel designer fentanyls \u2013 results from the Swedish STRIDA project","volume":"55","author":"Helander","year":"2017","journal-title":"Clin. Toxicol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.06.010_bib0110","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/bjd.15174","article-title":"Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45","volume":"176","author":"Helander","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.06.010_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1520\/JFS13045J","article-title":"Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases","volume":"36","author":"Henderson","year":"1991","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0120","doi-asserted-by":"crossref","unstructured":"INPS (2017). Marchard A., Martin-Molins C., Moal A., Vieira P., Sibille P., Milan N.L.,\u2019 Ocfentanil, un bon exemple des dangers des NPS (New Psychoactive Substances). Poster at French Society of Analytical Toxicology Congress, May 2017.","DOI":"10.1016\/j.toxac.2017.03.091"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-6576.1982.tb01765.x","article-title":"Potent, new analgesics, tailor-made for different purposes","volume":"26","author":"Janssen","year":"1982","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"37","key":"10.1016\/j.neubiorev.2018.06.010_bib0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.15585\/mmwr.mm6537a6","article-title":"Notes from the Field: furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine - British Columbia, Canada, July 15\u201318, 2016","volume":"65","author":"Klar","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0379-0738(97)00068-6","article-title":"A cluster of fentanyl-related deaths among drug addicts in Sweden","volume":"88","author":"Kronstrand","year":"1997","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2016.08.004","article-title":"Risk of fentanyl overdose among clients of the Sydney medically supervised injecting Centre","volume":"37","author":"Latimer","year":"2016","journal-title":"Int. J. Drug. Policy"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.06.010_bib0145","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ijd.12428","article-title":"Mucocutaneous manifestations of illicit drug use","volume":"53","author":"Lee","year":"2014","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.06.010_bib0150","article-title":"Homemade heroin substitute causing hallucinations","volume":"16","author":"Lemon","year":"2013","journal-title":"Afr. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.06.010_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: an opioid epidemic within an opioid epidemic","volume":"69","author":"Lucyk","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0160","first-page":"1","article-title":"The growing problem of new psychoactive substances (NPS)","volume":"32","author":"Madras","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajem.2008.12.009","article-title":"Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses","volume":"28","author":"Merlin","year":"2010","journal-title":"Am. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.06.010_bib0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/pme.12233","article-title":"Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management","volume":"15","author":"Michna","year":"2014","journal-title":"Pain Med. (Malden, Mass.)"},{"issue":"9","key":"10.1016\/j.neubiorev.2018.06.010_bib0175","first-page":"709","article-title":"Analysis of novel synthetic opioids u-47700, U-50488 and furanyl fentanyl by LC-MS\/MS in postmortem casework","volume":"40","author":"Mohr","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.06.010_bib0180","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.drugpo.2015.04.003","article-title":"Fentanyls: are we missing the signs? Highly potent and on the rise in Europe","volume":"26","author":"Mounteney","year":"2015","journal-title":"Int. J. Drug. Policy"},{"issue":"7","key":"10.1016\/j.neubiorev.2018.06.010_bib0185","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.drugpo.2015.04.003","article-title":"Fentanyls: are we missing the signs? Highly potent and on the rise in Europe","volume":"26","author":"Mounteney","year":"2015","journal-title":"Int. J. Drug. Policy."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.06.010_bib0190","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.amjmed.2014.01.040","article-title":"\u2018Krokodil\u2019 in the United States is an urban legend and not a medical fact","volume":"127","author":"Mullins","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0195","series-title":"National Coronial Information System. Deaths Related to Fentanyl Misuse \u2013 An Update (July 2000\u2013December 2012)","author":"NCIS","year":"2013"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0200","series-title":"National Drug EarlyWarning System (NDEWS). NDEWS Special Reports","author":"NDEWS","year":"2015"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.06.010_bib0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/add.13589","article-title":"Development of a proto-typology of opiate overdose onset","volume":"112","author":"Neale","year":"2017","journal-title":"Addiction (Abingdon, Engl.)"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0210","series-title":"U.S. Drug Enforcement Administration, Diversion Control Division. NFLIS Brief: Fentanyl, 2001-2015","author":"NFLIS","year":"2017"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0215","series-title":"National Institute on Drug Abuse","author":"NIDA\/NIH","year":"2016"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0220","series-title":"Synth\u00e8se th\u00e9matique : nouveaux produits de synth\u00e8se","author":"OFDT","year":"2017"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.06.010_bib0225","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcms.2014.05.005","article-title":"Surgical treatment of jaw osteonecrosis in \u201cKrokodil\u201d drug addicted patients","volume":"42","author":"Poghosyan","year":"2014","journal-title":"J. Cranio-Maxillo-Facial Surg."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.06.010_bib0230","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugpo.2016.10.006","article-title":"The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin","volume":"40","author":"Quintana","year":"2017","journal-title":"Int. J. Drug. Policy"},{"issue":"9","key":"10.1016\/j.neubiorev.2018.06.010_bib0240","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jat\/bks078","article-title":"Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use","volume":"36","author":"Riches","year":"2012","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0245","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jemermed.2015.10.014","article-title":"Acetylfentanyl: an emerging drug of abuse","volume":"50","author":"Rogers","year":"2016","journal-title":"J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/dta.2135","article-title":"Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples","volume":"9","author":"Rojkiewicz","year":"2017","journal-title":"Drug. Test. Anal."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","volume":"32","author":"Roxburgh","year":"2013","journal-title":"Drug. Alcohol. Rev."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0260","series-title":"French Society of Analytical Toxicology. SFTA Guidelines for the Achievement of Toxicological Analyzes for Deaths Involving NPS","author":"SFTA","year":"2017"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.06.010_bib0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(03)00027-0","article-title":"Salvinorin a: the \"magic mint\" hallucinogen finds a molecular target in the kappa opioid receptor","volume":"24","author":"Sheffler","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0270","series-title":"Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep","author":"Somerville","year":"2017"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.06.010_bib0275","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.06.010_bib0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: one pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical Fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug. Alcohol. Depend."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.06.010_bib0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03161089","article-title":"Dose-independent occurrence of seizure with tramadol","volume":"5","author":"Talaie","year":"2009","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: current understanding","volume":"47","author":"Uetrecht","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0300","series-title":"United Nations Office on Drugs and Crime, World Drug Report 2017. (ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3, United Nations Publication, Sales No. E.17.XI.6)","author":"UNODC","year":"2017"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0305","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1186\/s12889-015-2604-6","article-title":"Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia","volume":"15","author":"Uuskula","year":"2015","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.06.010_bib0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1874467210666170704110146","article-title":"Opioids in the frame of new psychoactive substances network: a complex pharmacological and toxicological issue","volume":"11","author":"Ventura","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.neubiorev.2018.06.010_bib0315","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2174\/092986709788682074","article-title":"Fentanyl analogs: structure-activity-relationship study","volume":"16","author":"Vuckovic","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0320","doi-asserted-by":"crossref","unstructured":"Waldhoer, M. S., Bartlett, E., and J., Whistler, L., (2004). Opioid Receptors.\" Annual Review of Biochemistry 73(1): 953-990 %U https:\/\/doi.org\/910.1146\/annurev.biochem.1173.011303.073940.","DOI":"10.1146\/annurev.biochem.73.011303.073940"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.06.010_bib0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","article-title":"Do Heroin overdose patients require observation after receiving naloxone?","volume":"55","author":"Willman","year":"2017","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"8","key":"10.1016\/j.neubiorev.2018.06.010_bib0330","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/dta.1856","article-title":"Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation","volume":"8","author":"Wohlfarth","year":"2016","journal-title":"Drug. Test. Anal."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.06.010_bib0335","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(25)09710-1","article-title":"The inactivation of cholinesterase by morphine, dilaudid, codeine and desomorphine","volume":"78","author":"Wright","year":"1943","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0340","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An expanding world of novel psychoactive substances: opioids","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2018.06.010_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.09.030","article-title":"Next generation of novel psychoactive substances on the horizon - a complex problem to face","volume":"157","author":"Zawilska","year":"2015","journal-title":"Drug Alcohol. Depend."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:33:21Z","timestamp":1758965601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763418301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":69,"alternative-id":["S0149763418301143"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.06.010","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New synthetic opioids: Part of a new addiction landscape","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}